In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

Nagpur: India is facing an alarming rise in cases of Retinopathy of Prematurity (ROP), a condition that can cause irreversible blindness in premature .

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...